Non-Sedating Antihistamines Rx-to-OTC Switch NDAC & PADAC Joint Meeting

10/18/01


Click here to start


Table of Contents

Non-Sedating Antihistamines Rx-to-OTC Switch NDAC & PADAC Joint Meeting

Overview

AllegraŽ Is Still a Relatively New Product

Seldane: Over 10 Years on the Market & 24 Million Patient Years Experience

Unprecedented & Unwarranted Switch Process

The Switch Could Have Unintended Patient Health and Safety Consequences

The Switch Could Have Unintended Patient Health and Safety Consequences

Blue Cross of California Petition

Liability Concerns

In Summary

FDA Questions

Non-Sedating Antihistamines Rx-to-OTC Switch NDAC & PADAC Joint Meeting

Author: nm07270